triazoles has been researched along with Fatty Liver in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 22 (75.86) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Braeuning, A; Lasch, A; Lichtenstein, D; Marx-Stoelting, P | 1 |
| Hong, N; Kim, SI; Park, S; Rhee, Y; Seo, DH; Sohn, JH; Yoon, HG | 1 |
| Braeuning, A; de Sousa, G; Durinck, S; Katsanou, ES; Konstantinidou, P; Lampen, A; Luckert, C; Machera, K; Milani, ES; Peijnenburg, AACM; Rahmani, R; Rajkovic, A; Rijkers, D; Spyropoulou, A; Stamou, M; Stoopen, G; Sturla, S; Wollscheid, B; Zucchini-Pascal, N | 1 |
| Fukui, K; Nangaku, M; Saito, H; Sugahara, M; Tanaka, S; Tanaka, T; Wakashima, T | 1 |
| Braeuning, A; Buhrke, T; Knebel, C; Lampen, A; Marx-Stoelting, P; Süssmuth, R | 1 |
| Akaslan, SB; Arslan, M; Cakir, N; Degertekin, CK; Toruner, FB; Yilmaz, G | 1 |
| Degli Antoni, A; Ferrari, C; Fragola, V; Manfredi, R; Weimer, LE | 1 |
| Anand, S; Bhatia, T; Olaywi, M; Singhal, S | 1 |
| Chew, GT; Sahebkar, A; Watts, GF | 1 |
| Aguilera-Lizarraga, J; Blanco, JR; Narro, J; Ochoa-Callejero, L; Oteo, JA; Pérez-Martínez, L; Pérez-Matute, P; Recio, E; Rubio-Mediavilla, S | 1 |
| Choi, YK; Jang, BK; Jung, GS; Jung, YA; Kim, HS; Kim, JG; Kim, MK; Lee, IK; Park, KG; Seo, HY | 1 |
| Chen, D; Deng, Y; Feng, G; He, P; Hu, R; Huang, T; Li, E; Li, L; Li, Y; Liang, Z; Lin, Y; Liu, J; Lu, Y; Ma, R; Su, F; Sun, S; Tong, Z; Wang, S; Wang, X; Wu, Y; Xu, Z; Zhang, H; Zhang, X; Zhang, Y; Zhao, Y | 1 |
| Hashizume, H; Horiguchi, N; Kakizaki, S; Kusano, M; Mori, M; Ohyama, T; Sato, K; Yamada, M; Yamazaki, Y | 1 |
| Bugeon, L; Cheung, J; Dallman, MJ; Lamb, JR; Marchesi, JR; McBrien, M; Progatzky, F; Sangha, NJ; Scott, J; Shia, A; Yoshida, N | 1 |
| Evans, A; Lacey, R | 1 |
| Aroor, AR; Dunham, MM; Ford, DA; Ford, KD; Habibi, J; Lastra, G; Manrique, C; Nistala, R; Parks, EJ; Rector, RS; Sowers, JR; Thyfault, JP | 1 |
| Hamada, H; Ishigure, T; Kakutani, M; Kume, S; Nishiu, J; Ohta, T; Okuma, C; Sakata, S; Sano, R; Tadaki, H; Taniuchi, H | 1 |
| Berger, JP; Berthiaume, M; Deshaies, Y; Festuccia, WT; Laplante, M; Thieringer, R | 1 |
| Fu, N; Li, LX; Liang, BL; Nan, YM; Wang, RQ; Wu, WJ; Yu, J; Zhao, JM; Zhao, SX | 1 |
| Cross, LB; Foard, J; Gross, BN; Wood, Y | 1 |
| Borelli, MI; Del Zotto, H; Flores, LE; Francini, F; Gagliardino, JJ; Madrid, VG; Maiztegui, B; Massa, ML; Raschia, MA; Rebolledo, OR | 1 |
| Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Celikel, CA; Deyneli, O; Duman, DG; Kalayci, C; Yilmaz, Y; Yonal, O | 1 |
| Isogawa, A; Iwamoto, M; Koike, K; Ohki, T; Ohsugi, M; Omata, M; Tagawa, K; Toda, N; Yoshida, H | 1 |
| Chen, M; Li, J; Sun, L; Wang, C; Zuo, Z | 1 |
| Currie, RA; Milburn, G; Moggs, JG; Pastoor, T; Peffer, RC; Rusyn, I; Waechter, F; Wright, J | 1 |
| Bellmann, R; Bellmann-Weiler, R; Graziadei, I; Joannidis, M; Vogel, W; Weiler, S; Zoller, H | 1 |
| Morii, S; Nakao, I; Nishimura, R; Shikata, N; Tsubura, A | 1 |
| Ishii, H; Ninobe, S; Suga, T | 1 |
2 review(s) available for triazoles and Fatty Liver
| Article | Year |
|---|---|
Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review.
Topics: Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Liraglutide; Liver; Non-alcoholic Fatty Liver Disease; Peptides; Pyrazines; Sitagliptin Phosphate; Transaminases; Treatment Outcome; Triazoles; Venoms | 2013 |
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides | 2014 |
1 trial(s) available for triazoles and Fatty Liver
| Article | Year |
|---|---|
A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer.
Topics: Aged; Anastrozole; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Liver; Middle Aged; Nitriles; Prospective Studies; Tamoxifen; Treatment Failure; Triazoles | 2014 |
26 other study(ies) available for triazoles and Fatty Liver
| Article | Year |
|---|---|
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells.
Topics: Adverse Outcome Pathways; Carcinoma, Hepatocellular; Cell Line, Tumor; Dioxolanes; Dioxoles; Fatty Acids; Fatty Liver; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Models, Theoretical; Pesticides; Pyrroles; Triazoles; Triglycerides | 2021 |
Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Incidence; Letrozole; Lipids; Middle Aged; Nitriles; Propensity Score; Retrospective Studies; Tamoxifen; Triazoles | 2017 |
Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole.
Topics: Adverse Outcome Pathways; Biological Assay; Cell Line, Tumor; Dose-Response Relationship, Drug; Fatty Liver; Fungicides, Industrial; Gene Expression; HEK293 Cells; Hepatocytes; Humans; Mitochondria, Liver; Models, Biological; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Risk Assessment; Triazoles; Triglycerides | 2018 |
Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.
Topics: Adipose Tissue, White; Animals; Body Weight; Diet, High-Fat; Fatty Liver; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; N-substituted Glycines; Obesity; Prolyl Hydroxylases; Pyridines; Triazoles | 2019 |
Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines.
Topics: Carcinoma, Hepatocellular; Cell Line; Fatty Liver; Fungicides, Industrial; Gene Knockout Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Pregnane X Receptor; Triazoles | 2019 |
Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
Topics: Alanine Transaminase; Animals; Blood Glucose; Cholesterol; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Female; Insulin; Insulin Resistance; Liver; Non-alcoholic Fatty Liver Disease; Obesity; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles; Triglycerides | 2013 |
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probab
Topics: Adult; Carbamates; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclohexanes; Drug Substitution; Drug Therapy, Combination; Fatty Liver; Furans; Hepatitis C, Chronic; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Male; Maraviroc; Organophosphates; Pyrrolidinones; Raltegravir Potassium; Sulfonamides; Triazoles | 2012 |
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD).
Topics: Animals; Cyclohexanes; Disease Models, Animal; Fatty Liver; Histocytochemistry; Liver; Liver Function Tests; Male; Maraviroc; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Triazoles | 2014 |
Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Topics: Animals; Biomarkers; Blotting, Western; Choline Deficiency; Diet; Dipeptidyl-Peptidase IV Inhibitors; Endoplasmic Reticulum Stress; Fatty Liver; Immunoenzyme Techniques; Inflammation; Lipid Peroxidation; Liver Cirrhosis; Male; Methionine; Mice; Mice, Inbred C57BL; NF-kappa B; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sitagliptin Phosphate; Triazoles; Triglycerides | 2014 |
MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Biomarkers; Cytoprotection; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Fatty Liver; Gene Expression Regulation; Lipogenesis; Liver; Male; Mice, Obese; Obesity; Signal Transduction; Time Factors; Triazoles; Triglycerides | 2014 |
Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation.
Topics: Animals; Benzoxazoles; Carrier Proteins; Caspase 1; Cholesterol, Dietary; Diet, High-Fat; Fatty Acids; Fatty Liver; Female; Immunity, Innate; Inflammasomes; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestines; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Myeloid Cells; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Triazoles; Zebrafish | 2014 |
An unusual cause of jaundice in a patient with breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Fatty Liver; Female; Humans; Jaundice; Liver; Liver Function Tests; Middle Aged; Nitriles; Triazoles | 2014 |
Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.
Topics: Animals; Blotting, Western; Body Composition; Ceramides; Diet, Western; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Mitochondria; Palmitates; Pyruvic Acid; Triazoles; Triglycerides | 2015 |
JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.
Topics: Acyltransferases; Animals; Antigens, Bacterial; Bacterial Proteins; Diglycerides; Disease Models, Animal; Enzyme Inhibitors; Fatty Acids; Fatty Liver; Gene Expression; Intestinal Absorption; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Piperazines; Sterol Regulatory Element Binding Protein 1; Triazoles; Triglycerides | 2015 |
Additive action of 11beta-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiponectin; Animals; Disease Models, Animal; Fatty Liver; Male; Obesity; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Rosiglitazone; Thiazolidinediones; Triazoles; Triglycerides | 2009 |
Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; bcl-2-Associated X Protein; Blotting, Western; Cyclooxygenase 2; Fatty Liver; Genes, bcl-2; Inflammation; Lipid Peroxidation; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Triazoles; Vitamin E | 2009 |
Elevated hepatic enzymes potentially associated with sitagliptin.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Humans; Liver; Liver Function Tests; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Diet; Dipeptidyl-Peptidase IV Inhibitors; Drinking; Drug Evaluation, Preclinical; Eating; Exenatide; Fatty Liver; Fructose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Metabolic Syndrome; Peptides; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Venoms | 2011 |
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles | 2011 |
Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis.
Topics: Adult; Body Mass Index; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Female; Hepatocytes; Humans; Male; Middle Aged; Pilot Projects; Pyrazines; Sitagliptin Phosphate; Triazoles | 2012 |
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.
Topics: Adult; Alanine Transaminase; Blood Glucose; Body Weight; Comorbidity; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Inflammation; Liraglutide; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Odds Ratio; Pioglitazone; Platelet Count; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles | 2012 |
Chronic exposure to paclobutrazol causes hepatic steatosis in male rockfish Sebastiscus marmoratus and the mechanism involved.
Topics: Animals; Fatty Liver; Fishes; Gene Expression Profiling; Gene Expression Regulation; Lipids; Liver; Triazoles; Water Pollutants, Chemical | 2013 |
Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor.
Topics: Administration, Oral; Animals; Antigens, Differentiation; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Cytochrome P450 Family 2; Diet; Dose-Response Relationship, Drug; Enzyme Induction; Fatty Liver; Fungicides, Industrial; Gene Expression Regulation; Gene Silencing; Hepatocytes; Hypertrophy; Liver; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Phenobarbital; Proto-Oncogene Proteins c-mdm2; Receptors, Androgen; Species Specificity; Steroid Hydroxylases; Triazoles; Vacuoles | 2007 |
Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis.
Topics: Antifungal Agents; Fatty Liver; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Improved lipid visualization with a modified osmium tetroxide method using ultrasonic treatment and intensification with imidazole or triazole.
Topics: Fatty Liver; Histocytochemistry; Humans; Imidazoles; Lipids; Liver; Osmium Tetroxide; Proteolipids; Staining and Labeling; Tissue Fixation; Triazoles; Ultrasonics | 1995 |
Effect of 3-amino-1,2,4-triazole treatment on catalase activity and triglyceride level in fatty liver of the rat.
Topics: Amitrole; Animals; Carbon Tetrachloride Poisoning; Catalase; Ethanol; Ethionine; Fatty Liver; Female; Male; Rats; Triazoles; Triglycerides | 1977 |